Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 NICE guidance on bortezomib and thalidomide for first-line treatment of multiple myeloma.

Literature DB >> 21984992

NICE guidance on bortezomib and thalidomide for first-line treatment of multiple myeloma.

Sally Doss, Nicola Hay, Frances Sutcliffe.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2011 PMID： 21984992 DOI： 10.1016/s1470-2045(11)70202-9

Source DB: PubMed Journal: Lancet Oncol ISSN： 1470-2045 Impact factor: 41.316

Keyword Cloud
Cited

× No keyword cloud information.

2 in total

Review 1. Value of innovation in hematologic malignancies: a systematic review of published cost-effectiveness analyses.

Authors: Cayla J Saret; Aaron N Winn; Gunjan Shah; Susan K Parsons; Pei-Jung Lin; Joshua T Cohen; Peter J Neumann
Journal: Blood Date: 2015-02-05 Impact factor: 22.113

Review 2. Bortezomib in multiple myeloma: systematic review and clinical considerations.

Authors: T C Kouroukis; F G Baldassarre; A E Haynes; K Imrie; D E Reece; M C Cheung
Journal: Curr Oncol Date: 2014-08 Impact factor: 3.677

2 in total